On October 17, 2025, Hongda Group welcomed an important visit. Academician Zheng Yuguo, a leading authority in China’s biotechnology field, led his team to the Group for an exchange and held a productive discussion with Chairman Shi Liliang on strategic cooperation. The visit brought a forward-looking academic perspective to Hongda and created new consensus and momentum for deeper industry–university–research collaboration.

Accompanied by Group Deputy General Manager Zhang Chenghu, Academician Zheng and his delegation first visited Hongda Group’s niacin production base. During the tour, Academician Zheng carefully reviewed the complete innovation chain, from fermentation-process development to quality control. He expressed high recognition of Hongda Group’s breakthroughs in high-quality production and offered valuable suggestions on key technical steps in the process.

The subsequent meeting took place in a practical and forward-looking atmosphere. Chairman Shi Liliang warmly welcomed Academician Zheng and his team and gave a systematic overview of the company’s industrial layout and research achievements in amino acids, antibiotics and other fields. He emphasized that Hongda has always been committed to turning cutting-edge science into practical solutions and serving people’s lives with higher-quality products.

Academician Zheng spoke highly of Hongda Group’s technical path and development strategy. In light of the latest global trends in biotechnology, he offered a series of strategic recommendations on jointly building new technology platforms and optimizing processes. The two sides held in-depth discussions on pathways for integrating industry, universities and research in amino-acid production, reached a number of shared understandings, and initially established a framework of cooperation intentions. They also exchanged views on talent development and the construction of innovation platforms, further deepening their understanding and mutual trust.

The visit by the academician’s team was not only a high-level academic exchange but also a key milestone in advancing industry–research coordination. It marks a new stage in the relationship between Hongda Group and top research teams and injects strong momentum into the company’s innovation-driven development. Next, the Group will use this opportunity to organize and advance the outcomes of the meeting, work with the academician’s team to create a new win-win chapter, and contribute to the high-quality development of the biotechnology industry.